recent articles
Why clearer, more actionable reports could drive wider AI adoption in diagnostics If you had asked Flora Abilova 20 years ago where she saw herself, she might have pictured a courtroom, arguing cases with the sharp precision of a seasoned...
Deep Bio: Integrating Deep Bio's DeepDx Prostate Algorithm into PathAI's AISight IMS Platform SEOUL, SOUTH KOREA, November 19, 2024 /EINPresswire.com/ -- Deep Bio, a leader in artificial intelligence for digital pathology, announced a...
SEOUL, SOUTH KOREA, August 6, 2024 /EINPresswire.com/ -- Deep Bio Inc., a leader in AI-driven digital pathology solutions, announced the publication of an external validation study for its DeepDx Prostate AI algorithm, conducted by Stanford...
Deep Bio utilizes deep learning-based algorithms to differentiate breast cancer lesions accurately, optimizing diagnostic accuracy SEOUL, SOUTH KOREA, May 21, 2024 /EINPresswire.com/ -- Deep Bio today announced the publication of a study...
Deep Bio: Three posters will be presented at the AACR Annual Meeting 2024 to spotlight Deep Bio's pioneering research and advancements in AI within digital pathology SEOUL, SOUTH KOREA, March 28, 2024 /EINPresswire.com/ -- Deep Bio, a...
SEOUL, South Korea, Oct. 4, 2023 /PRNewswire/ -- Deep Bio, a leader in artificial intelligence (AI)-powered cancer diagnostics, announced today that it has been named to the Korea AI Startup 100 list. This prestigious list, representing a...






























